By buying this product you can collect up to 4 loyalty points. Your cart will total 4 points that can be converted into a voucher of 1,00 €.
Inpa Moduprost Prostate Health 90vcaps - plant combination that aims to reduce the volume of prostate cells
Warning: Last items in stock!
No. Known. EOF: 24 278
To ModuProst is an absolutely vegetable combination that aims to reduce the volume of prostate cells, reduce inflammation, and generally improve the functioning of the genitourinary system.
A study published in the Lancet showed a large reduction of symptoms caused by prostatic hypertrophy (frequent urination, urinary tract infections, etc.) afflicting large percentage of men especially after 60 years.
Also available on the Internet many studies for all components of ModuProst.
Dosage: Two capsules daily, morning and evening, preferably on an empty stomach at least one hour before eating.
In difficult cases proposed combined use of Moduprost product with OL IP-6, for best results.
Studies available on the internet:
1) Randomised, placebo-controlled, double-blind clinical trial of betasitosterol in patients with benign prostatic hyperplasia. Lancet. 1995 Jun 17; 345 (8964): 1529-32.
2) Effect of lycopene on androgen receptor and prostate-specific antigen velocity. Chin Med J (Engl). 2010 Aug; 123 (16): 2231-6.
3) A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. Br J Urol. 1997 Sep; 80 (3): 427-32.
4) Treatment of symptomatic benign prostatic hyperplasia with betasitosterol: an 18-month follow-up. BJU Int. 2000 May; 85 (7): 842-6.
5) Aqueous extract of Urtica dioica makes significant inhibition on adenosine deaminase activity in prostate tissue from patients with prostate cancer. Cancer Biol Ther. 2004 Sep; 3 (9): 855-7.
6) Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention. Cancer Prev Res (Phila). 2010 Aug; 3 (8): 985-93.
7) Lycopene and apo-12'-lycopenal reduce cell proliferation and alter cell cycle progression in human prostate cancer cells. Nutr Cancer. 2011; 63 (2): 256-63.
8) Phytotherapy for benign prostatic hyperplasia. Public Health Nutr. 2000 Dec; 3 (4A): 459-72.
9) Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study. J Herb Pharmacother. 2005; 5 (4): 1-11. PMID: 16635963.
No customer comments for the moment.